优化后续心血管药物在重症监护室的重新引入
Hadjer Dahel1, Najla Tabbara2, Lisa Burry2
1Faculty of Pharmacy, Université de Montréal, QC, Canada.
Canadian journal of kidney health and disease
|September 9, 2024
概括
危急病患者经常在ICU中停止心血管药物治疗,特别是氨酸-血管激素系统阻断剂. 这凸显了对这些患者改善药物调和和重新启动方案的需要.
科学领域:
- 临床药房 临床药房
- 关键护理医学 关键护理医学
- 心血管药理学心血管药理学
背景情况:
- 由于严重疾病而入院的医院住院扰乱了药物治疗方案,导致了潜在的差异.
- 慢性心血管疾病药物经常在重症监护室 (ICU) 中断或改变.
- 心血管药物重启ICU后的最佳时间尚未确立.
研究的目的:
- 为了确定慢性心血管药物停用在重症患者的患病率.
- 确定与心血管药物停用在ICU和医院出院时相关的因素.
主要方法:
- 在加拿大两个高等学术医院进行多中心的回顾性队列研究.
- 包括在ICU入院前服用心血管药物的成年患者,这些患者在出院后幸存下来.
- 通过图表审查评估药物停用.
主要成果:
- 包括352名患者;44.03%的人至少停止服用一种心血管药物.
- 与停药相关的因素包括男性性别,更高的入院前心血管药物数量和血管压缩剂的使用.
- 素-血管素系统 (RAS) 阻断剂经常被停止使用.
结论:
- 心血管药物停用在ICU幸存者中很常见.
- 这些发现支持加强药物调和协议,并制定RAS阻断剂重新启动策略.
- 需要进一步研究最佳的心血管药物重新启动时间.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
Heart Failure Drugs: Inotropic Agents
543
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
543
Heart Failure Drugs: β-Blockers
321
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
321
Heart Failure Drugs: Diuretics
350
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
350
Exercise and Cardiovascular Response
746
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
746
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K


